How much profit has Alexion Pharmaceuticals made this year?
Alexion Pharmaceuticals has made 3.99 B USD this year.
In 2024, Alexion Pharmaceuticals's profit amounted to 3.99 B USD, a 5.88% increase from the 3.77 B USD profit recorded in the previous year.
YEAR | NET INCOME (undefined USD) |
---|---|
2025e | - |
2024e | - |
2023e | - |
2022e | - |
2021e | - |
2020 | - |
2019 | - |
2018 | - |
2017 | - |
2016 | - |
2015 | - |
2014 | - |
2013 | - |
2012 | - |
2011 | - |
2010 | - |
2009 | - |
2008 | - |
2007 | - |
2006 | - |
2005 | - |
2004 | - |
2003 | - |
2002 | - |
2001 | - |
In the annual report of the Alexion Pharmaceuticals share (US0153511094, 899527, ALXN), it breaks down its revenues into 1 segments: 1. Therapies. The Alexion Pharmaceuticals stock (WKN: 899527, ISIN: US0153511094, Ticker Symbol: ALXN) is a leading investment for investors interested in participating in the Health Care sector.
The profit margins of Alexion Pharmaceuticals represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Alexion Pharmaceuticals's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Evaluating Alexion Pharmaceuticals's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Alexion Pharmaceuticals's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
When Alexion Pharmaceuticals’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Alexion Pharmaceuticals has made 3.99 B USD this year.
The profit has increased by 5.88% compared to last year increased
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
Alexion Pharmaceuticals publishes its earnings in the form of quarterly or annual reports.
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
The profits of Alexion Pharmaceuticals are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
You can learn more about the earnings of Alexion Pharmaceuticals by reviewing the quarterly or annual reports or following the company presentations.
Over the past 12 months, Alexion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alexion Pharmaceuticals is expected to pay a dividend of 0 USD.
The current dividend yield of Alexion Pharmaceuticals is .
Alexion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
Alexion Pharmaceuticals paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
Alexion Pharmaceuticals is assigned to the 'Health' sector.
To receive the latest dividend of Alexion Pharmaceuticals from 5/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.
The last dividend was paid out on 5/13/2024.
In the year 2023, Alexion Pharmaceuticals distributed 0 USD as dividends.
The dividends of Alexion Pharmaceuticals are distributed in USD.
The Alexion Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic
Our stock analysis for Alexion Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alexion Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.